Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Stanley Black & Decker, Inc. ( SWK - Analyst Report ) recently issued junior subordinated debentures worth $750 million; maturing on July 25, 2052. The issue was offered at $25 per debentures or 100% of principal amount.
The debentures carry a coupon rate of 5.75% to be paid quarterly by the company, with the first installment accruing on September 15, 2012. The debentures carry a Baa2 rating from Moody’s, BBB+ from S&P and BBB from Fitch.
In the recently reported second quarter 2012 results, the company reported a 0.6% sequential increase in its long-term debt balance (net of current portions) which settled at approximately $2.9 billion. Net interest expense in the quarter rose 20.5% to $32.3 million.
Also, the quarter’s earnings per share from continuing operations came in at $1.32, down 9.6% from $1.46 reported in the year-ago quarter. GAAP EPS including 40 cents of merger related charges was 92 cents compared with $1.14 in the second quarter of 2011. Net revenue increased 8.1% year over year to roughly $2.8 billion, due primarily to a 1% unit volume improvement, a 1% positive price impact and 10% positive impact from acquisitions. These were, however, offset by a 4% negative currency translation impact.
The current Zacks Consensus Estimate for the third quarter of 2012 is $1.60, representing a year-over-year increase of 19.48%. Estimates for the fiscal years 2012 and 2013 are $5.60 and $6.55, reflecting annual growth of 6.87% and 16.93%, respectively.
Stanley Black & Decker manufactures tools and engineered security solutions across the globe. Prime competitors of the company are Danaher Corp. ( DHR - Analyst Report ) , Makita Corp. ( MKTAY ) , and Snap-on Inc. ( SNA - Analyst Report ) .
We currently maintain a Neutral recommendation on Stanley Black & Decker. The stock also bears a Zacks #5 (Strong Sell) Rank.
Read the full on MKTAY
Read the full Analyst Report on DHR
Read the full Analyst Report on SWK
Read the full Analyst Report on SNA